A PHASE IIa RANDOMIZED, CONTROLLED, DOUBLE- MASKED, CROSSOVER CLINICAL TRIAL DESIGNED TO EVALUATE THE SAFETY AND EXPLORATORY EFF
Hampar Karageozian email address & phone number | Allegro Ophthalmics, LLC President and CEO contact information - RocketReach
![On-Sight Interview with Vicken Karageozian, MD, President & CEO, Allegro at OIS@AAO 2019 | Ophthalmology Innovation Source On-Sight Interview with Vicken Karageozian, MD, President & CEO, Allegro at OIS@AAO 2019 | Ophthalmology Innovation Source](https://i.ytimg.com/vi/Bs1p_MRWaRU/maxresdefault.jpg)